Govt has formulated national policy for rare diseases: Nadda

Image
Press Trust of India New Delhi
Last Updated : Feb 28 2018 | 11:40 PM IST
Union Health Minister J P Nadda today said the government had formulated a national policy for "rare diseases", while asserting that the process of preparing a registry of such diseases was already initiated.
He also said full support from the government to provide cost-effective management and investigation facilities to the patients suffering from rare diseases would be provided.
"The government has formulated a national policy for rare diseases. The process of preparing a registry of rare diseases has already been initiated by the health ministry," Nadda said, after inaugurating a day-long conference to mark the "World Rare Disease Day" here. Union minister Jitendra Singh was also present on the occasion.
Nadda said even though the prevalence of such diseases was very low, but the government had formed a body to focus on this area of healthcare, both directly by the health ministry as well as by other agencies affiliated to it.
A newsletter published by the "Indian Organisation of Rare diseases" was also released on the occasion.
Noting that it was an irony that the "rare diseases" were rarely discussed, Singh pointed out that the reason for this was that the healthcare system of the country was preoccupied with more prevalent diseases, while these "rare diseases", usually genetic or existing from the birth, had a prevalence of hardly about seven per cent.
He said most of the literature available on these diseases was written by Western authors.
Even the definition was based on Western inferences, like in the USA, a disease was said to be "rare" if it affected less than two lakh people, while in Europe, it was categorised as a "rare" disease if it affected not more than five persons per 10,000 people, Singh said.
"Therefore, there is a dire need of compiling the Indian data for these diseases, based on the epidemiological, phenotype and other factors peculiar to India," he added.
Singh said in the larger perspective, some of the diseases, which were rare in India till about three decades ago, had suddenly become widely prevalent throughout the country.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 28 2018 | 11:40 PM IST

Next Story